Panminerva Medica 2009 September;51(3)

  PERITONEAL DIALYSIS

Panminerva Medica 2009 September;51(3):139-50

Expanding criteria for peritoneal dialysis use

Palomar R., Arias M.

Abstract PDF

  PERITONEAL DIALYSIS

Panminerva Medica 2009 September;51(3):151-61

Cardiovascular disease in peritoneal dialysis patients

Fassett R. G., Driver R., Healy H., Coombes J. S.

Abstract PDF

  PERITONEAL DIALYSIS

Panminerva Medica 2009 September;51(3):163-73

The role of nutritional status in the outcome of peritoneal dialysis patients

Grzegorzewska A. E.

Abstract PDF

  PERITONEAL DIALYSIS

Panminerva Medica 2009 September;51(3):175-85

Metabolic consequences of peritoneal dialysis treatment

Gallieni M., Musetti C., Granata A., Olivi L., Bertoli S.

Abstract PDF

LETTERS TO THE EDITOR  

Panminerva Medica 2009 September;51(3):187-8

The use of IFN-a in subjects with liver transplant for hepatitis C

Gattoni A., Plaitano E., Vangieri B., Parlato A., Giordano A.

PDF

LETTERS TO THE EDITOR  

Panminerva Medica 2009 September;51(3):188

How many patients with HCC have normal des-gamma-carboxy prothrombin and alpha-fetoprotein levels?

Castelli A.

PDF